Quantifying the risk of blood transfusion with myomectomy

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Quantifying the risk of blood transfusion with myomectomy
Like

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

Quantifying the risk of blood transfusion with myomectomy

As the most common benign tumor in reproductive-age women, uterine fibroids are estimated to affect up to 80% of women (1). Although the majority are asymptomatic, a large proportion of those who do experience fibroid-related symptoms report a significant negative impact on quality of life. In one n…

Volume 114, Issue 1, Pages 79–80

Authors:

Joseph Findley, M.D., Rebecca Flyckt, M.D.

Abstract:

Reflections on "Myomectomy associated blood transfusion risk and morbidity following surgery" by Kim et al.

Read the full text here. 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.

Sign In Register

Recommended Content